Exane Derivatives’s Barclays BCS Stock Holding History

Exane Derivatives’s Portfolio BCS Stock Details BCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1	Closed	-$11	–	628
2017 Q4	$11	Sell	1 -2	-67%	-$19	﹤0.01%	601
2017 Q3	$31	Sell	3 -54,732	-100%	-$543K	﹤0.01%	549
2017 Q2	$551K	Buy	54,735 +17	+0%	+$173	0.12%	131
2017 Q1	$585K	Buy	+54,718	New	+$588K	0.13%	123
2016 Q4	–	Sell	-47,056	Closed	-$386K	–	649
2016 Q3	$386K	Buy	+47,056	New	+$372K	0.06%	167
2016 Q2	–	Sell	-94,709	Closed	-$852K	–	559
2016 Q1	$765K	Buy	+94,709	New	+$883K	0.1%	107
2015 Q2	–	Sell	-134,226	Closed	-$1.82M	–	527
2015 Q1	$1.82M	Buy	134,226 +45,156	+51%	+$633K	0.2%	66
2014 Q4	$1.24M	Buy	+89,070	New	+$1.22M	0.17%	92

Other funds holding BCS

Eagle Capital Management (New York) New York $32.7B AUM 17.15% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CCM

Causeway Capital Management Los Angeles, California $9.24B AUM 21.27% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $10.5B AUM 30.38% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Exane Derivatives's BCS Position: Q1 2018 in Review

Exane Derivatives sold out of Barclays (BCS) in Q1 2018, closing a stake of 1 share — an estimated $11 sold.

Exane Derivatives first reported a position in BCS in Q4 2014 and held it in 8 quarters. The position peaked at $1.82M in Q1 2015. 253 funds tracked by Wall St. Rank hold BCS as of Q1 2018.

Exane Derivatives reported no remaining Barclays position as of Q1 2018 after selling out during the quarter.
Exane Derivatives sold 1 Barclays share in Q1 2018, an estimated $11.
Exane Derivatives first reported a position in Barclays in Q4 2014 and held it in 8 quarters.
Exane Derivatives's Barclays position peaked at $1.82M in Q1 2015.
253 funds tracked by Wall St. Rank held Barclays as of Q1 2018.

Based on Exane Derivatives's 13F filing for Q1 2018, filed 30 Apr 2018.